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ABSTRACT
Pentoxifylline enhances the toxicity of radiation and has emerged as an
effective modulator of the radiation response of tumour cells. The molecular
mechanisms involved in the enhancement of radiotoxicity by pentoxifylline
have not yet been elucidated. Cell cycle blocks, DNA repair and programmed
cell death (apoptosis) are all pert of the cellular response to DNA damage and
as such must be considered as targets of the drug. In this study, the influence
of pentoxifylline on radiosensitisation, G2 block abrogation, DNA repair
inhibition and the induction of apoptosis have been investigated in 8e11 and
MeWo melanoma and 4197 and 4451 squamous cell carcinoma (SCC) cell
lines. The influence of pentoxifylline on radiation-induced apoptosis in Jurkat
J5 T-lymphocytic leukemia cells has also been assessed. Hela cervical
carcinoma cells were used to investigate the molecular events involved in the
abrogation of the G2 block by pentoxifylline. It is shown that pentoxifylline
preferentially sensitises the TP53 mutant MeWo and 4451 cell lines and
enhances radiotoxicity by factors of up to 14.5. In the MeWo melanoma, but
not in the 4451 SCC cell line, radiosensitisation is accompanied by inhibition
of DNA repair. No significant enhancement of radiation-induced apoptosis
was observed in MeWo melanoma and 4451 SCC cells. However, Jurkat J5
cells showed an increase in apoptosis after irradiation in the presence of the
drug. In irradiated Hela cervical carcinoma cells, pentoxifylline affects the
expression of the two components of the mitosis promoting factor (MPF),
namely cyclin 81 and p34cdC2, and rapidly restores cyclin 81/p34cdC2 ratios to
control levels. Analysis of cyclin 81 expression in whole cells and isolated
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nuclei furthermore reveals an influence of the drug on the subcellular
translocation of the MPF.
It is concluded that G2 block abrogation is not the only mechanism involved in
the radiosensitisation of tumour cells by pentoxifylline, but that DNA repair
inhibition plays a role in certain cell types. Although pentoxifylline induces
apoptosis in Jurkat J5 thymocytes, radiation-induced apoptosis plays no role
in the radiosensitisation of the two TP53 mutant melanoma and sec cell
lines. Abrogation of the G2 block by pentoxifylline, which sensitises tumour
cells to a second irradiation or chemotherapeutic challenge, involves a
modulation of the levels of cyclin 81 and p34cdC2, and the subcellular location
of the MPF. These results are of utmost importance for the clinical potential of
pentoxifylline as a dose modifier in cancer therapy.
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OPSOMMING
Pentoxifylline verhoog die toksisiteit van bestraling en het dus na vore getree
as 'n effektiewe modulator van die sellulêre stralingsrespons in kankerselle.
Die molekulêre meganismes betrokke by die verhoging van stralings-
toksisiteit deur pentoxifylline is egter nog nie duidelik nie. Blokkering van die
selsiklus, die herstel van ONS skade en geprogrammeerde seldood
(apoptose) vorm almal deel van die sellulêre respons ná bestraling en word as
sulks beskou as potensiële teikens van die middel. In hierdie studie is die
invloed van pentoxifylline op stralings-sensitiwiteit, G2 blok verwydering, die
vertraging van ONS herstel en die indusering van apoptose ondersoek in die
Be11 en MeWo melanoom en 4197 en 4451 plaveisel-sel karsinoom sellyne.
Die invloed van pentoxifylline op stralings-geïnduseerde apoptose in Jurkat J5
T-limfosiete is ook bestudeer. Hela servikale karsinoom selle is gebruik om
die molekulêre gebeurtenisse rondom die verwydering van die G2 blok deur
pentoxifylline te ondersoek. Dit word aangetoon dat pentoxifylline by voorkeur
die radiosensitiwiteit van die TP53 mutante MeWo en 4451 sellyne verhoog,
en stralingstoksisiteits verhogingsfaktore van tot 14.5 genereer. Hierdie effek
gaan gepaard met die vertraging van ONS herstel in die MeWo melanoom,
maar nie in die 4451 plaveisel-sel karsinoom sellyn nie. Die meting van
apoptose toon geen noemenswaardige verhoging van stralings-geïnduseerde
apoptose in MeWo melanoom óf in 4451 plaveisel-sel karsinoom selle nie.
Jurkat J5 T-limfosiete toon egter wel 'n verhoging in apoptose wanneer
bestraling in die teenwoordigheid van pentoxifylline gedoen word. In Hela
servikale karsinoom selle affekteer pentoxifylline die uitdrukking van die twee
komponente van die mitose promoverings faktor (MPF), naamlik siklien B1 en
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p34CdC2, en restoreer die siklien 81/p34cdC2 verhoudings vinnig na normale
vlakke. Ontleding van die siklien 81 uitdrukking in heel selle en in geïsoleerde
selkerne toon verder dat die middelook die sub-sellulêre ligging van die MPF
affekteer.
Die gevolgtrekking word gemaak dat G2 blok verwydering nie die enigste
meganisme is waardeur pentoxifylline radiosensitiwiteit verhoog nie, maar dat
die vertraging van ONS herstel in sommige seltipes 'n rol speel. Alhoewel
pentoxifylline apoptose verhoog in T-limfosiete, speel dit nie 'n rol in die
verhoogde radiotoksisiteit wat waargeneem is in die TP53 mutante melanoom
en plaveisel-sel karsinoom sellyne nie. Verwydering van die G2 blok deur
pentoxifylline, wat selle meer sensitief kan maak vir 'n tweede stralings- of
chemoterapie aanslag, behels die modulasie van siklien 81 en p34cdc2 vlakke
en die sub-sellulêre ligging van die MPF. Hierdie resultate is van uiterste
belang vir die kliniese aanwending van pentoxifylline as 'n dosis-modifiseerder
in kankerterapie.
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CHAPTER 1
General Background
1.1 Radiotherapy and radiosensitising drugs in cancer
treatment
Radiation and surgery are currently the most effective treatment modalities in
cancer therapy. Nearly 60% of all tumours receive radiotherapy and
radiotherapy in combination with surgery remains the cornerstone for the
long-term control of most tumours (Steel, 1993). Radiotherapy often achieves
excellent tumour control with good cosmetic results in tumours of the head
and neck, cervix, bladder, prostate and skin (Bartelink, 1988). In addition to
the curative role, radiation is also used for palliation in a variety of
malignancies to reduce pain and increase survival time (Ash bey, 1991).
However, radioresistance and late effects remain major problems in the clinic
(Steel, 1991; Merkle, 1987; Turesson 1989; Dunne-Daly, 1995). Thus
considerable efforts are being devoted to the improvement of radiotherapy.
The possibility of improving tumour control by a change in treatment strategy
must always be accompanied by a consideration of the effects on tumour
response and damage to the surrounding normal tissue. In curative cancer
therapy, the so-called therapeutic index is of critical importance (Steel, 1988).
This is defined as the tumour response for a fixed level of normal-tissue
damage and carries the notion of a "cost-benefit" analysis (Steel, 1993). A
simplified example of how this can be attained by combining a cytotoxic drug
1
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with radiotherapy is given in Figure 1. These drugs are called
radiosensitisers, and consist of pharmacological agents which increase
radiotoxicity when administered in conjunction with radiation (Adams, 1972).
Many radiosensitisers have been discovered over the years, but most offer no
practical gain in clinical radiotherapy because the toxicity difference between
tumour and normal tissues, also called therapeutic index, is too low.
Application of this concept in the clinic is not straightforward, and the clinical
evaluation of potential radiosensitisers is difficult. The search for effective
radiosensitisers which enhance tumour cell death and spare normal tissue
thus continues.
Radiosensitisers currently in use include hypoxic sensitisers such as
metronidazole, halogenated pyrimidines such as BrdU and IrdU, DNA
synthesis inhibitors e.g. fluorouracil and methotrexate, alkylating agents e.g.
cyclophosphamide and antibiotics such as doxorubicin, which intercalate
between DNA strands and block RNA production (Nias, 1990). Some of
these drugs and their site of action are shown in Figure 2. When the all
important criterion of a differential effect between tumour and normal cells are
applied, only the halogenated pyrimidines and the hypoxic cell sensitisers
have found practical use in clinical radiotherapy on the basis of the faster
cycling of tumour cells, and the preferential sensitisation of oxygen deprived
tumour cells, respectively (Spiro et ai, 1985; Kinsella 1992, McGinn and
Kinsella, 1993). Effective dose levels are often associated with high toxicity
and the use of these drugs remains problematic (Fowler and Kinsella 1996).
2
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Figure 1
With drug
II'Q
U
Ó
_j
ru
E
It...
Cl
Z
Radiation
alone
/
• Max. tolerated level
Radia tien do s.e
The procedure by which an improvement in therapeutic index
might be identified, as a result of combining radiotherapy and a
cytotoxic drug. The maximum tolerated level of normal tissue,
indicated in the lower diagram, remains the same. However,
tumour control with the drug (8) improves as compared to that
with irradiation alone (A), as shown in the upper diagram (From
Steel. 1993)
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The rapidly increasing knowledge of cell and molecular biology now offers
better insight into how cells respond to radiation and this has lead to new
concepts of improving radiotherapy with drugs (Maity et ai, 1997). The aim is
to achieve a favourable therapeutic index at non-toxic dose levels. Genes
and transcription pathways activated by radiation are now being defined. The
mechanisms involved in radiation-induced DNA repair and cell cycle delays
are also being elucidated. The role of the tumour suppressor gene TP53 in
cell cycle delay and apoptosis is a particularly active field of study. The
formation and abrogation of radiation-induced cell cycle blocks, and drug-
induced modulation of radiation-induced apoptosis and DNA repair offer
exciting new avenues for the improvement of cancer therapy. Agents which
influence damage response mechanisms of tumour cells are now the focus of
oncological research world wide.
1.2 Pentoxifylline
1.2.1 Chemical structure, toxicity and pharmacology
The chemical structures of pentoxifylline [1-(5-oxohexyl)-3, 7-dimethylxanthine]
and caffeine [1,3,7 -trimethylxanthine] are closely related and are given in
Figure 3. Toxicity studies using four representative tumour cell lines, show
TD50 (toxic dose causing 50% cell death) values of 3.17 - 6.0 mM and 2.24 -
3.92 mM for pentoxifylline and caffeine respectively. This indicates that
pentoxifylline is less toxic than caffeine in cell culture by a factor of 0.5, and
hence also more suitable for human administration. Throughout this study,
pentoxifylline was used at a sub-toxic dose of 2 mM.
5
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Figure 3
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Chemical structures and molecular weights of the two closely
related methylxanthines, pentoxifylline and caffeine.
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In the human body, absorption of pentoxifylline from the gastro-intestinal tract
following oral administration is rapid and almost complete (Smith et ai, 1986;
Bryce et ai, 1989). Peak plasma levels are attained within 2-4 hours.
Metabolism occurs in both erythrocytes and the liver where pentoxifylline is
metabolised to Metabolite I [1-(5-hydroxyhexyl)-3, 7-dimethylxanthine] and
Metabolite V [1-(3-carboxypropyl-3, 7-dimethylxanthine] respectively (Hawkins
and Ribeiro, 1987; Ward and Clissold, 1987, Honess et ai, 1993). Plasma
levels of these metabolites are 5 to 8 times higher than that of pentoxifylline.
The plasma half lives of pentoxifylline and its metabolites are 0.4-0.8 hand
1.6-1.8 h respectively. Excretion is primarily renal. The pharmacokinetics of
pentoxifylline in cell culture is not known.
1.2.2 Current clinical applications
Pentoxifylline is used clinically for a wide variety of disorders. These include:
intermittent claudication (Aviado and Porter, 1989), chronic peripheral heart
and cerebrovascular disease (Ward and Clissold, 1987; Windmeier and
Gressner, 1997), and the improvement of sperm motility (Shen et ai, 1991).
The efficacy of pentoxifylline is based on the following: inhibition of
phosphodiesterase, increase of cAMP activity, reduction of plasma fibrogen
concentrations, and improved erythrocyte flexibility, blood viscosity and blood
flow.
Pentoxifylline also inhibits the production of tumour necrosis factor alpha
(TNF-a), a naturally occuring cytokine with many functions in the human
7
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immune system (Tracey and Cerami, 1994; Schendene et ai, 1992). TNF-a
activates CD44, a cell adhesion receptor which facilitates the attachment of
white cells to the endothelium in the inflammatory immune response (Tracey
and Cerami, 1994; Weiss et ai, 1995). Its role in the inhibition of the synthesis
and action of several other cytokines like TNF-y, IL-1, IL-6 and GM-CSF in
CD8+ cytotoxic lymphocytes has more recently been demonstrated (Lundblad
et al, 1995; Heinkelein et al, 1995). Pentoxifylline reduces the replication of
HIV-1 in vitro in acutely infected human T-cells (Fazely et ai, 1991). This is
also attributed to its reduction of cellular TNF levels. It is therefore not
surprising that pentoxifylline is effective in the treatment of inflammatory
diseases, septic (endotoxic) shock and infection, thrombosis, ulcers and
leprosy (Lundblad et ai, 1995). Pentoxifylline is also applied in patients for the
treatment of HIV infection, and in organ transplantation as an anti-
inflammatory agent (Eugene-Jolchine and Milpied, 1995).
Pentoxifylline clearly has a multi-functional pharmacological profile and
operates at various levels. It is therefore not surprising that the full spectrum
of pentoxifylline action has not been elucidated and that more effects of the
drug are being discovered and investigated. The use of pentoxifylline in
cancer therapy as a radio- and chemosensitiser also is a new area of
research.
8
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1.3 Potential molecular targets for manipulating the radiation
response
1.3.1 Cell cycle checkpoints
Irradiation of cells causes a transient division delay which may include a G1
arrest, an S-phase delay, or a G2 arrest (Figure 4). It is attractive to
speculate that cell cycle delays may play an important role in cell survival
following DNA damage and there is currently a great interest in understanding
the controlling mechanisms. The movement of cells through the cell cycle,
and the induction of cell cycle blocks, e.g. by irradiation, are controlled by
cyclin proteins and enzymes called cyclin dependent kinases (cdk's)
(Maclachlan et ai, 1995; Dirks and Rutka, 1997). Specific cyclins act with
specific cdk's at different points in the cell cycle as shown in Figure 4. For
example, the cyclin 81/p34cdC2 and the cyclin E/cdk 2 complexes are crucial
for the G2/M and G1/S transitions, respectively (Gong et ai, 1994). There is
also a third class of proteins involved, namely the cdk inhibitors, which can
regulate the cell cycle by binding to and inactivating cdk's. Several cdk
inhibitors have been identified, of which p21 (waf/cip), which is induced via
TP53, is a very important example (Harper et ai, 1995; Gartel et ai, 1996).
While the molecular events resulting in the formation of the G1 block are
relatively well established and involve the TP53 pathway (Kastan et ai, 1991),
very little is known about the signalling initiated by DNA damage which gives
rise to a G2 delay. The G2 block occurs as a result of many different types of
DNA damage regardless of TP53 status (Hwang and Muschel, 1998). Some
• lJ. S, .•
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Figure 4
Cyclin 81/cdc2
cyclin Alcdc2
Cyclin 01,2 or 3
/ cdk2,4 or 6
Rb phosphorylation
and E2F activation
Molecular regulation of the cell cycle. Different cyclins such as A,
81, D1, D2, D3 and E complex with specific cyclin dependent
kinases (cdk's) during specific phases of the cell cycle. DNA-
damaging agents, including ionising radiation, can arrest cells in the
G1, Sand G2 phases of the cell cycle (Adapted from Maity et ai,
1997).
10
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evidence does exist for a role of TP53-activities in the G2 block (Winters et ai,
1998) and it is also possible that other TP53 independent mechanisms are
involved. It has now been established that the formation of an active mitosis
promoting factor (MPF), consisting of cyclin B1 and its cdk, p34cdC2, is
essential for the transition of cells from G2 into mitosis (Murray et ai, 1989,
Broek et ai, 1991). The activity of this complex is regulated by two
independent mechanisms: firstly by the synthesis of cyclin B1 and secondly
by a series of phosphorylations on p34cdC2 (also known as cdk1). Formation
of a cyclin B1/p34cdC2 complex is required for p34cdC2 histone H1 activity. For
this purpose, there is a ten-fold rise in cyclin B1 expression in the G2 cell
cycle phase, and a rapid elimination of cyclin B1 by cell cycle-specific
ubiquitination during the final stages of mitosis (Murray 1992). The p34cdC2
molecule is phosphorylated at threonine 161. When cyclin B1 binding
occurs, phosphorylation at threonine 14 and tyrosine 15, mediated by Myt1
and Wee1 kinases respectively, blocks activity of the complex. Enzymatic
activity of the complex is triggered through the activation of cdc25C, a dual-
specific phosphatase, which removes both phosphates at Thr14 and Tyr15
(Murray 1992). Activation is further regulated by the sub-cellular location of
the MPF complex (Li et ai, 1997). The biochemical reactions involved in the
activation of the MPF are represented in Figure 5.
There is currently a great deal of interest to increase radiation-induced tumour
cell death by manipulating cell cycle checkpoints, especially the G2/M
checkpoint. Agents which inhibit the G2 cell cycle delay are caffeine and
pentoxifylline, which belong to the family of methylxanthines (Russell et ai,
11
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Figure 5
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The molecular control of mitotic entry. The expression and
binding of cyclin 81 and p34cdC2 leads to the formation of an
inactive mitosis promoting complex (MPF). This complex is
activated by various phosphorylation and dephosphorylation
steps as shown. Pi refers to a phosphate group, and the
numbers indicate the amino acids on p34cdC2 involved in the
phosphorylation reaction. Cyclin 81 is rapidly eliminated
following mitotic entry (adapted from Hwang and Muschel, 1998).
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1996). Since many tumour cells have a mutated TP53 gene and
consequently cannot arrest at the G1 checkpoint, a possibility exists to target
cancer cells (Russell et ai, 1996; Hwang and Muschel, 1998). In normal TP53
wild type cells, the G1 checkpoint would be intact. Irradiation of normal
tissues thus would induce a G1 arrest to permit repair and cellular recovery.
This could have far-reaching clinical implications as it facilitates the sparing of
normal tissue. It has been argued that selective activation of checkpoints may
be the underlying reason why some drugs are effective at all in tumour
therapy (Waldman et ai, 1997). The detailed mechanisms of action of such
drugs however remains to be elucidated.
1.3.2 DNA repair
Ionising radiation induces various types of DNA damage, including double
strand breaks (dsb), single strand breaks (ssb), base damage and DNA-
protein erosslinks (Arrand and Michael, 1992). DNA dsb induction and repair,
and the fidelity of DNA repair, seem to be critical factors which determine
radiosensitivity in human tumour cell lines (Nunez et ai, 1996). Because of
this, much effort has been made in trying to understand the molecular
mechanisms leading to the repair of radiation-induced DNA damage. This
has lead to the identification of the XRCC5 gene, which encodes the 80-kD
sub-unit of Ku (Weaver, 1995). Along with another protein called p350, this
forms the DNA-dependent protein kinase (DNA-PK) complex thought to be
involved in DNA dsb repair (Anderson, 1993). Ku targets the damaged DNA
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by attaching to the DNA termini, whereas p350 is the catalytic sub-unit
containing kinase activity. Enzymes which are activated by DNA strand
breaks, e.g poly(ADP-ribose) Polymerase (PARP) and Mdm-2, have been
implicated as possible role-players in the sensing of DNA damage (Burkle et
ai, 1992; Momand and Zambetti, 1997). PARP is thought to indirectly activate
TP53, p21 and DNA-PK (Le Ruhn et al, 1998).
Further work in determining the specific proteins involved in detecting and
repairing radiation induced DNA damage may have potential clinical
applications. One could target Ku, p350, PARP, or another protein yet to be
discovered which acts downstream, thus rendering cells more radiosensitive
by preventing the recognition of DNA damage. New drugs which are capable
of inactivating these repair proteins and hence inhibit dsb repair are being
sought. In this strategy, the preferential targeting of tumour cells over normal
tissues remains an ever important problem.
1.3.3 Programmed cell death (Apoptosis)
Apoptosis is a distinct form of cell death which is essential for normal
development and tissue homeostasis (Wyllie et ai, 1980). Apoptosis has
several distinctive features which distinguish it from necrosis (Searle et ai,
1982). These are chromatin condensation, cell shrinkage, membrane
blebbing and DNA degradation at internucleosomal linkages (Wyllie et ai,
1981). This results in the characteristic DNA repeat ladder which becomes
apparent in DNA electrophoretic gels. Apoptotic cells are usually scattered
14
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throughout tissue rather than occurring in a large block of contiguous cells as
found in necrosis (Searle et ai, 1982). In contrast to necrosis, inflammation is
absent in apoptosis. Unlike necrosis, apoptosis arises from activation of a
specific gene program. It has been described as death from the inside out. In
the cell, the apoptosis is initiated by a cascade of highly specialised non-
random events of protein and DNA-cleavage. Protein cleavage results from
activation of a family of cysteine proteases or "caspases", while DNA is
cleaved by endonucleases (Peter and Krammer, 1998). The activation of
these processes can only start if the cell has sensed damage and signalled
this to the appropriate cell machinery. A number of tumour-suppressor genes
such as TP53 and oncogenes such as myc and bc/-2 have been implicated in
the recognition and signalling process (Konopleva et ai, 1999). Intricate
pathways leading to apoptotic death have been identified, e.g. the ceramide
pathway (Venable et ai, 1995; Mizushima et ai, 1996), the stress-activated
protein/jun kinase (SAPKlJNK) cascade (Kasibhatla et al, 1998), and the
mitogen-activated protein kinase/extracellular-signal regulated (MAPKlERK)
pathway (Blagosklonny, 1998). Several other molecules like bcl-2, BAX and
other pro- and anti-apoptotic molecules determine the survival "threshold" of a
certain cell type (Reed, 1995). A simplified diagram describing the basic
apoptotic pathways is given in Figure 6.
There is some evidence that apoptosis may playa role in radiosensitivity
(Zhivotovsky et ai, 1999). It has been noted that certain cells in normal
mammalian tissues which are susceptible to natural apoptosis e.g.
haematopoetic tissues, are particularly radiosensitive (West 1995). Since
15
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Figure 6
Apoptotic pathways
Ionising radiation
(Induce DNA strand breaks)
TNF-related apoptosis inducing ligand
Hormone
e.g. glucocorticoid
Pro-apoptolic genca:
e.g. bax, 1PS3, c-jun
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apoptosis appears to be a natural process inherent in cells and is inducible by
specific stimuli, understanding of its regulation has considerable application
in tumour biology. The hope is to selectively activate apoptotic pathways in
tumour cells but not in normal tissue, thereby achieving effective tumour cell
death while minimising normal tissue complications. This goal has not yet
been accomplished. Various kinase and phosphatase inhibitors as well as
growth factors and cytokines have been shown to alter the apoptotic response
of cells in vitro, and it is possible that the same approach could someday be
used clinically. Since TP53 is an important regulator of apoptosis which is
mutated in 60% of all tumours (Lee and Bernstein, 1995), restoring wild type
function may reverse tumour resistance to apoptosis. However, this is no
trivial task. An alternative approach would be to prevent apoptosis in normal
tissues and thereby reduce late radiation side-effects. Cytokines which inhibit
apoptosis, such as basic fibroblast growth factor (bFGF), have been
administered to mice immediately before a lethal dose of irradiation to the
whole lung. This prevented the development of radiation pneumonitis (Fuks
et ai, 1994). Although these results are preliminary in nature, they are
extremely interesting and suggest a way in which the apoptotic response may
be manipulated for clinical benefit. Another future approach for selective
killing of tumour cells lies in the understanding of the reasons for tumour
survival despite substantial genomic damage. If the DNA damage and
mutations which induce tumours could be harnessed as a signal for the cell to
self-destruct (apoptose), the survival threshold for cancer cells would be
lower, while normal cells lacking the DNA damage-signal may be spared
(Hickman, 1998).
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1.4 Role of TP53 in damage responses
DNA damage initiates a signal transduction pathway ultimately resulting in
increased levels of TP53 protein. Through sequence-specific DNA binding,
TP53 can modulate transcription of a variety of target genes following DNA
damage (Enoch and Norbury, 1995). Wild type TP53 plays a role in the
induction of a G1 arrest, DNA repair and apoptosis following DNA damage
(Lee and Bernstein, 1995). The TP53 mediated G1 arrest results from the
transactivation of several cellular molecules, in particular p21 and gadd45
(O'Connor, 1997; Hwang and Muschel, 1998). p21 inhibits CDKlcyciin activity
which indirectly suppresses the expression of the transcription factor E2F,
required for the expression of S-phase-specific genes. This causes a G1
arrest (Gartel et al, 1996). The high levels of p21 and gadd45 increases
repair mediated by proliferating cell nuclear antigen (PCNA) and DNA
excision (Prosperi, 1997). The mdm-2 gene is positively regulated by TP53,
and inhibits TP53 function (Wetzel and Berberich, 1998). TP53 activation
also leads to the synthesis of cyclin G, which is thought to be involved in G2
arrest (Shimitzu et ai, 1998). TP53 induces apoptosis through pathways
which are not yet fully understood, but is thought to involve activation of the
ICE proteases and the BAX gene which acts as a positive regulator (Enoch
and Norbury, 1995). Bcl-2 inhibits apoptosis (Hickman, 1998). The rise in
TP53 levels also brings about transcription of a number of other genes,
summarised in Figure 7.
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A diagram of TP-53 signalling in the irradiated mammalian
cell (From Szumiel, 1998). TP53 plays a key role in cell
cycle blocks, DNA repair and apoptosis following DNA
damage.
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Since the TP53 protein is involved in all known damage responses and might
also playa role in G2 arrest (this is still ill-defined), the cellular TP53 status
plays a crucial role in cell survival. The downstream effects of TP53 have
lead to contradictory hypotheses regarding the influence of TP53 status on
radiosensitivity (Bristow et ai, 1996). For example, TP53 wild type could
increase apoptosis leading to increased cell death, while it could also induce a
G1 or/and G2 arrest and increase DNA repair leading to increased cell
survival. Many contradicting reports have been published in this regard (for
review see Morgan and Kastan, 1997), which may be explained by the fact
that TP53 dependent apoptosis and G1 arrest followed by DNA repair and
cellular recovery appears to be controlled by different donwstream pathways
and that the activity of these pathways is cell type specific. The fact that a
large amount of tumour types exhibit mutated TP53 genes distinguishes them
from normal cells. It may be possible to exploit this to preferetially kill tumour
cells. One example is the preferential chemo- and radiosensitisation of TP53
mutant tumour cell lines by radiosensitising agents which abrogates the G2
cell cycle block.
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1.5 Thesis objective
The search for radiosensitisers which can enhance radiotoxicity at non-toxic
dose levels, is currently a focal point in radiobiological research. It is of
critical importance that these drugs can distinguish between normal and
tumour cells. This would lead to improved local tumour control, while late
radiation effects would be reduced through sparing of the surrounding normal
tissue. Pentoxifylline, a methylxanthine closely related to caffeine, has been
shown to act as a radiosensitiser both in vitro and in vivo at sub-toxic doses
(Lau and Pardee, 1982; Vernimmen et al, 1984; Kim et al, 1993). However,
its mechanism of action have not yet been elucidated.
This study addresses the following important questions:
1. Can the enhancement of radiotoxicity by pentoxifylline be solely attributed
to the early induction of mitosis through G2 block abrogation?
2. Does pentoxifylline influence the repair of radiation-induced DNA damage?
3. Does the drug enhance radiotoxicity by increasing radiation-induced
apoptosis?
4. Which molecular events are involved in the abrogation of radiation-induced
G2 cell cycle blocks by pentoxifylline?
5. Does the drug have the potential to discriminate between normal and
tumour cells?
This information will contribute greatly to a better understanding of the
radiosensitising effects of pentoxifylline. Specific tumour types likely to benefit
21
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from a radiotherapy/pentoxifylline combination may also be identified. This
study thus could have far-reaching implications for the improvement of cancer
therapy.
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Chapter 2
Introduction
The G1/S and G2/M transitions have been recognised as important
checkpoints in the response of cells to DNA damage. It is commonly thought
that delays in the G1 and G2 phases of the cell cycle, which typically reaches
a maximum at 12-24 hours post-irradiation, are protective mechanisms which
prevent propagation of defective DNA (for review see Maity et ai, 1997). The
G1 cell cycle checkpoint is dependent on the activation of wild type TP53 and
is absent in TP53 mutant cells (Kastan et ai, 1991). Although a recent study
on human ovarian cells shows that wild type TP53 can inhibit G2/M transition
by decreasing intracellular cyclin B1 levels (Innocente et ai, 1999), the G2/M
checkpoint is generally activated in response to DNA damage irrespective of
TP53 status (Kastan et ai, 1991). G2 delays are induced by exposure to a
variety of DNA damaging agents including ionising radiation (Weinert et aI,
1988), DNA alkylators (Konopa et al, 1988) and topoisomerase inhibitors
(Barlogie et al, 1976).
The relationship between G2 arrest and cell survival is not clearly established.
Prolongation of the G2 arrest has been correlated with increased
radioresistance in Hela cervical carcinoma and MeWo melanoma cells
(Tamamoto et ai, 1999). Agents which reduce the G2 delay sensitise cells to
ionising irradiation (Bernhard et ai, 1996; Kim et ai, 1992). It has also been
shown that the irradiation-induced G2 block in human lymphocytes is
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associated with unrejoined chromosome fragments (Durante et ai, 1999).
Other authors have failed to demonstrate a correlation between the duration
of the G2 block and radiosensitivity, although the frequency of unrejoined
chromosome breaks increased with attenuation of the G2 block (Schwartz et
al, 1996).
Methylxanthines like caffeine sensitise human tumour cells to ionising
irradiation when the TP53 gene is disrupted (Bracey et ai, 1997). The clinical
use of caffeine is limited, however, because of neurological and cardiac
toxicities (Dobmeyer et ai, 1983; Curatolo and Robertson, 1983). More recent
studies have evaluated other derivatives, which are more potent and less
toxic (Russell et ai, 1996). Pentoxifylline has been shown to sensitise human
and rodent cells to ionising irradiation (Vernimmen et ai, 1994; Kim et ai,
1993) and chemotherapeutic agents (Fingert et al, 1988; Li et al, 1999). lts
toxicity is lower than that of caffeine (Fingert et ai, 1986). Pentoxifylline
rapidly abrogates the irradiation induced G2 cell cycle checkpoint (Russell et
al, 1996).
The increased cell death observed when pentoxifylline is combined with
irradiation has been attributed to the ability of the drug to induce early mitosis
(Li et ai, 1998), which shortens the time for DNA repair (O'Connor, 1997,
Durante et al, 1999). However, the evidence for this hypothesis is
inconclusive, because DNA repair is completed within 12-16 hours after
irradiation and G2 blocks in the absence of pentoxifylline generally last up to
40 hrs (Binder et ai, 2000). Therefore, earlier damage response processes
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like DNA repair and apoptosis may also play a role in the radiosensitisation
effects of pentoxifylline.
The influence of caffeine and pentoxifylline on the induction of DNA repair is
still ambiguous. Several authors report caffeine to inhibit DNA repair in
human cells (Yasutake et al, 1995; link et al, 1995; Tempel and Von
Zallinger, 1997) while others found no effect (Smeets et ai, 1994). Split dose
experiments on V79 and Hela cells showed pentoxifylline to inhibit DNA
repair (Vernimmen et ai, 1994). Data on chinese hamster ovary (CHO) cells
have shown that pentoxifylline inhibits the elimination of cyclobutane
pyrimidine dimers (CPO's) induced by UV irradiation (Link et ai, 1996). If
pentoxifylline indeed is an agent which inhibits the repair process, one may
expect the number of DNA dsb remaining after the completion of repair to be
greater.
Data on the role of caffeine and pentoxifylline in apoptosis induction are also
inconclusive. In irradiated Hl-60 cells, caffeine has been found to decrease
apoptosis by up to 50% (Ning and Knox, 1999). Studies on human bladder
cancer cell lines have shown that the drug has no influence on apoptosis
(Ribeiro et ai, 1999). This is in contrast with findings that G2 block abrogation
by caffeine leads to increased apoptosis when combined with ionising
irradiation in human colorectal cells (Bracey et ai, 1997), human leukaemic
cells (Efferth et ai, 1995), murine T-Iymphoma cells (Palyoor et ai, 1995) and
Hela human cervical carcinoma cells (Bernhard et ai, 1996). It had been
suggested that the induction of apoptosis by caffeine is cell type specific
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(Crompton, 1998) and that the cytocidal effects of caffeine are separate from
cell cycle modulation (Takagi et ai, 1999). Pentoxifylline has been shown to
inhibit spontaneous and chemically induced apoptosis in neutrophils and
U937 cells (8elloc et ai, 1995). The inhibition of UV8 induced apoptosis in
HaCaT cells has been attributed to suppression of TNF-alpha release
(Schwartz et ai, 1997). However, in mouse leukaemic L1210 cells, drug-
induced apoptosis has been shown to increase when cells were treated in the
presence of pentoxifylline (Rauko et ai, 1998).
The molecular events involved in the G2 block abrogation effect of
pentoxifylline have not yet been elucidated. The entry of G2 cells into mitosis
is dependent on the activation of the maturation promoting factor (MPF) which
contains a 34 kDa serine threonine cyclin dependent protein kinase, p34cdC2
(Steinman et ai, 1991; Murray 1992; Norbury and Nurse, 1992). Kinase
activity is controlled by the formation of a complex between p34cdC2 and the
mitotic cyclin 81 protein (Murray et al, 1989; 8roek et al, 1991). Upon cyclin
81 binding, p34cdC2 becomes phosphorylated at threonine 161, which
promotes affinity for cyclin 81, and at threonine 14 and tyrosine 15 by the
Wee1 kinase, which inhibits kinase activity (McGowan and Russel, 1993).
The subsequent dephosphorylation of threonine 14 and tyrosine 15 residues
by the cdc25 phosphatases activates p34cdC2 kinase (Murray, 1992). The
activation is also regulated by the subcellular location of the p34cdC2 complex
(Li et al, 1997, Moore et al, 1999). The cyclin 81/p34cdc2 complex, which is
localized in the cytoplasm during interphase, is transported into the nucleus at
the onset of mitosis (Pines and Hunter, 1991) and then phosphorylates
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nuclear substrates e.g. the condensin complex (Murray, 1998). It is clear that
the formation and activation of the MPF complex is controlled at multiple
levels. It is now generally thought that control of entry into mitosis involve the
expression of cyclin B1 (Muschel et al, 1991, Maity et al, 1996) and p34 cdc2
(lock and Ross, 1990), the activation of the MPF complex by
dephosphorylation (McGowan and Russel, 1993) and subcellular
translocation (Li et ai, 1997, Moore et ai, 1999). The possibility therefore
exists that pentoxifylline could exert its block abrogating effect at any of these
control levels.
In order to identify the molecular events which control the formation of the G2
cell cycle delay, numerous attempts have been made to determine the
expression of the cyclin B1 proteins in response to DNA damage. Using
synchronised cells, it was shown that irradiation suppresses cyclin B1
expression when cells go into the G2 block (Muschel et al. 1991, O'Connor et
al. 1993, ling et al. 1996, Tsao et al. 1992; Kao et al, 1993). A study on the
effects of caffeine on Hela cells has shown that this drug elevates cyclin B1
expression while diminishing the cell cycle block (Bernhard, McKenna and
Muschel, 1994 a). Studies on asynchronous cells however failed to
demonstrate a significant reduction in cyclin B1 expression after irradiation
(Cohen-Johnathan et al. 1997, Villa et al. 1996), whereas one study reported
a dose-dependent increase in cyclin B1 expression concominant with the rise
in the G2/M fraction in both synchronised and asynchronous cultures
(Smeets, Mooren and Begg, 1994).
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In order to resolve these discrepancies, we wondered about the need of using
synchronous cells and the complications arising from unscheduled expression
of cyclins and other cellular proteins as described by Gong, Traganos and
Darzynkiewics (1995). The confusing reports on changes in protein
expression in asynchronous cells can be attributed to the sharp rise in the
numbers of G2 cells during block formation, which obscures the change in the
relative proportions of cyclin 81 to G2 cells. To avoid these pitfalls, we have
used asynchronously growing cells, and calculated the relationship between
G2 levels and cyclin 81 levels, which has not previously been measured.
P34cdc2 expression has previously been measured by flow cytometry in
polyploid cells (8aroja et aI, 1996). To our knowledge this aspect has not
been investigated flow cytometrically in response to DNA damage and G2
block abrogation. Some authors suggest that the levels of p34cdC2 remains
constant throughout the cell cycle and also after irradiation (McGowan and
Russel, 1993; lock and Ross, 1990; lock, 1992). Our flow cytometric results
in Hela cells allowed us to correlate p34cdC2 expression directly with cell cycle
stage and showed a higher percentage of p34cdC2 expression in the G1 and
G2 phases, with an increase in p34cdC2 expression in G2 during the radiation
induced G2 block. As with the measurement of cyclin 81 expression, the
p34cdC2 expression was measured here by calculating p34cdc2/G2 ratios.
Previous studies on the subcellular location of MPF have shown that the
cyclin 81/p34cdc2 complex is localised in the cytoplasm during interphase and
transported into the nucleus at the onset of mitosis (Tassen et al; 1994, Pines
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and Hunter, 1991). This was confirmed by using a fusion protein between
cyclin 81 and green fluorescent protein to trace the movement of MPF in
subcellular components (Hagting et aI, 1998). Cyclin 81 has been reported to
appear in the cytoplasm during late S phase, and then moves to the
perinuclear region and during G2 enters the nucleus, where it is concentrated
during mitosis (Kakina et aI, 1996). A unique cytoplasmic pool of cyclin 81
has also been documented for actively dividing cells, which rapidly increases
during S-phase and G2 phase and is then translocated to the nucleus during
early prophase where it forms a complex with the nuclear subset of p34cdC2
(David-Pfeuty et aI, 1996). It is now generally thought that the inactive cyclin
81/p34 complex indeed shuttles between the nucleus and cytoplasm in
human cells (Pines, 1999).
In this study we have examined the influence of pentoxifylline on
radiosensitivity, G2 checkpoint control, DNA repair and apoptosis in four
human cell lines of defined TP53 status, namely, the human melanoma cell
lines 8e11 (TP53 wild type) and MeWo (TP53 mutant) and the human
squamous cell carcinoma (SCC) cell lines 4197 (TP53 wild type) and 4451
(TP53 mutant). To assess the possibility of a cell type specific effect on
apoptosis, we have also measured the influence of pentoxifylline on radiation-
induced apoptosis in the Jurkat J5 human lymphocytic leukemia cell line.
Using asynchronous Hela cells, which produce a strong G2 block and in
which cyclin 81 expression is well characterised (8ernhard et ai, 1994a), we
determined the cyclin 81/G2 and p34cdC2/G2 ratios over a timespan of 25
hours after the induction of a G2 cell cycle block and in response to G2 block
29
Stellenbosch University http://scholar.sun.ac.za
abrogation by pentoxifylline. The influence of pentoxifylline on the subcellular
location of the MPF complex was assessed by analysing cyclin 81 expression
in isolated nuclei and in whole cells after exposure to ionising irradiation and
after G2 block abrogation.
The objective of this study was to clarify the modus operandi of pentoxifylline
as a dose-modifying drug and to highlight the role of repair and apoptosis for
cell types in which the drug increases radiotoxicity. These results also clarify
the molecular events which contribute to the formation of the radiation
induced G2 cell cycle delay and the mechanism of action of pentoxifylline as a
G2 block abrogator.
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Chapter 3
Materials and methods
Cell culture
The human melanoma cell lines, Be11 (TP53 wild type), MeWo (TP53
mutant), and the human SCC cell lines, 4197 (TP53 wild type) and 4451
(TP53 mutant), were kindly provided by F. Zëlzer and C. Streffer, University of
Essen, Germany. The TP53 mutations in the MeWo and 4451 are identical,
namely a G-to-A transition in codon 258 of exon 7, which lead to the
substitution of glutamine with lysine (Zëlzer et ai, 1995). Cells were grown in
MEM with 20% Foetal Bovine Serum (FBS), 2ml/l 1-glutamine, penicillin (100
U/ml) and streptomycin (100 !lg/ml) in 75 cm2 culture flasks incubated at 37°C
in 95% O2/ 5% C02. Jurkat J5 human lymphocytic leukemia cells were grown
in suspension in RPMI medium with 10% FBS, containing penicillin (100U/ml)
and streptomycin (100 !lg/ml). Asynchronous populations of Hela cervical
carcinoma cells were plated in McCoy's medium supplemented with Penicillin
(100 U/ml), Streptomycin (100 ug/ml) and 10% FCS in 75 cm2 cell culture
flasks and cultured at 37°C in 95% O2 / 5% C02.
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Drug toxicity
The cytotoxicity of pentoxifylline in the 8e11, MeWo , 4197 and 4451 cell lines
over a dose range of 0.5-4 mM was measured using the crystal violet assay.
Pentoxifylline was added to cells seeded at a density ranging from 5000-
10,000 cells/well, depending on the growth rate of each cell line, in 24-well
multiweIl plates, and medium changed after 24 hours. Cells were fixed four
days later in buffered formalin (pH 7.2) and stained with 0.01% crystal violet.
To determine the drug concentration at which the cell survival was reduced to
50% (T050), the extracted dye was read spectrophotometrically at 590 nm,
after overnight extraction with 10% SOS.
Irradiation procedures
For measuring cell survival, the 8e11, MeWo, 4197 and 4451 cell lines were
irradiated with 60Co-y doses ranging from 0-10 Gy. For the induction of a G2
arrest, a single dose of 7 Gy 60Co_y-rays were applied in all cell lines. For this
setup the source-to-sample distance (SSO) was 80 cm, the field size
30x30cm and the dose rate approximately 2 Gy/min. For the CFGE repair
experiments, the 8e11, MeWo, 4197 and 4451 cell lines were irradiated on
ice with 60Co_ y-ray doses ranging from 0-100 Gy at a dose rate of
approximately 3.2 Gy/min. The SSO for this setup was approximately 6 cm
and the field size was 30x35 cm.
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Flow cytometric determination of G2 block expression and abrogation
Exponentially growing cells in 25 cm2 culture flasks were irradiated with a
dose of 7 Gy 60Co y-irradiation. This was followed by harvesting cells at 2-
hourly time intervals for up to 40 hours by trypsinisation, centrifugation and
fixation in 70% ethanol at -20°C. The DNA content of these cells was
measured to determine the time of maximum G2 block expression. Briefly,
cells were stained in PBS containing 10 J..lg/mlpropidium iodide solution (PI,
Sigma, St. Louis) and 100J..lg/mlRNase (Boehringer Mannheim) at 370C for 30
minutes. Analysis was done on a FACScan (Becton Dickinson, San Diego,
USA) flow cytometer at 488 nm. Red fluorescence (PI) was collected as a
linear signal and recorded as a measure of the total DNA content. Cell
doublets were gated out by processing red fluorescence into area and width.
Estimates of cells in the different cell cycle stages, obtained by placing
markers on DNA histograms, revealed the time of maximum G2 block
expression.
Cell survival
Radiosensitisation induced by pentoxifylline (2 mM) added immediately prior
to irradiation, and pentoxifylline added at the time of maximum G2 block
expression was assessed by clonogenic assays in the Be11, MeWo, 4197
and 4451 cell lines. Cells were seeded into 25 crrr' culture flasks to yield
approximately 100-200 colonies. After cell attachment and drug treatment,
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these flasks were irradiated with 0,2,4,6,8 and 10 Gy of 60Coy-irradiation. In
samples where pentoxifylline was added at maximum G2 block expression,
the cells were exposed to a single dose of 7 Gy 60Co y-irradiation. After an
incubation period of two weeks, colonies containing more than 50 cells were
scored to measure cell survival and counts were adjusted for plating efficiency
(PE). Radiosensitisation by pentoxifylline is expressed as an enhancement
factor (REF), which is given by the ratio of surviving fractions:
REF = SF (Control) I SF (+ pentoxifylline).
DNA repair (CFGE) assay
The amount of DNA double strand break damage was determined by
constant-field gel electrophoresis (CFGE) as described previously (Wlodek et
ai, 1991). Confluent cultures were used to avoid S-phase variations between
cell lines (Dikomey et ai, 1998). Cells were encapsulated in agarose during
irradiation and repair. This procedure was optimized according to Kysela et al
(1993) in order to minimize non-specific DNA damage. In short, cells were
harvested by trypsinisation and resuspended in a 0.5% low melting agarose
solution. Aliquots of 30 JlI, containing -0.5 x 105 cells, were placed into each
well of a disposable plug mold (BioRad), and allowed to solidify at 4°C for 45
minutes. Plugs were irradiated in ice-cold MEM containing 2% HEPES, over
a dose range of 0-100 Gy 60Co y-irradiation on ice. Samples for the
determination of initial damage were immediately submitted to subsequent
lysing and washing steps. The residual damage was determined either in the
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presence or in the absence of pentoxifylline, by incubating plugs at 37°C in
growth medium for periods of 2h and 20h.
For both protocols (initial and residual damage), plugs were submersed in an
ice-cold lysing solution containing 50 mM EDTA, 1% N-Iauryl-sarcosine and 1
mg/ml Proteinase K. Incubation of 1h at 4°C was followed by lysing at 37°C
for 20hrs. Agarose plugs were then washed five times and stored in 2ml of 50
mM EDTA solution.
Agarose plugs were loaded into a 20 x 20 cm 0.6% agarose gel and run in 0.5
x TBE buffer for 30h at a constant field strength of 1.2 V/cm. Gels were
stained with ethidium bromide (0.5 !lg/ml in 0.5xTBE) and subjected to
fluorometric analysis with aGeneSnap (VacuTec) image analysis system.
The fraction of DNA released from the plug was obtained from the following
equation: Frei = flrel / (flplug + flrel), where flrel and flplug correspond to
fluorescence measured in the lane (DNA released) and in the plug
respectively. Untreated control samples were used for each sample subset to
subtract background fluorescence caused by non-specific DNA degradation.
Dose response curves were obtained by plotting dose (Gy) vs. the fraction of
DNA released (Frei) as calculated above, representing initial damage (Oh),
residual damage (2h), residual damage (2h) in the presence of pentoxifylline,
residual damage (20h) and residual damage (20h) in the presence of
pentoxifylline. Since data could not be fitted by linear regression, data points
were connected and the area under the curve (AUC) was calculated for each
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curve in the GraphPad Prism (GraphPad software, San Diego, USA)
computer program. Repair inhibition fators were calculated as follows:
AUC ratio withoutpentoxifylline/ AUC ratiowithpentoxitvlllne-
Apoptosis measurements
Cells exhibiting the characteristic membrane changes associated with
apoptosis were identified with Annexin-V-Fluos (Boehringer Mannheim,
Germany) (for review see Van Engeland et al, 1998). Adherent cells were
harvested by gentle scraping and were combined with cells floating in the
growth medium, whereas cells in suspension (Jurkat J5 cells) were used as
is. Approximately 106 cells were then incubated for 10-15 min. in Annexin-V-
Fluos staining solution containing 1!lg/ml Annexin-V reagent and 1!lg/ml PI in
binding buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM NaCI and 5 mM
CaCI2). Analysis was done on a FACScan flow cytometer at 488 nm, using a
515 nm bandpass filter for fluorescein detection, and a bandpass filter >560
nm for PI detection. Dot plots in log-scale of FL-1 vs. FL-3 were used to
identify the live (Annexin and PI negative) population, as well as early
apoptotic (Annexin-V positive, PI negative), late apoptotic (Annexin-V and PI
positive), and necrotic (Annexin negative, PI positive) populations. Apoptosis
was measured in cells irradiated with 7 Gy of 60Coy-irradiation at 24 and 48
hour time intervals after irradiation alone, or in the presence of pentoxifylline.
Data trends were confirmed by measuring the appearance of a sub-G1 peak
in DNA flow histograms obtained by flow cytometry as described above (data
not shown).
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Determination of the G2 block in Hela cells
The determination of the time of maximum cell cycle block in G2 was done by
irradiating exponentially growing Hela cells with 7Gy of 60Coy-irradiation, and
sampling cells at 2-hourly intervals for up to 24 hours. The cells were fixed in
70% ethanol and stored overnight at -20°C. For block abrogation studies,
samples in exponential phase were irradiated with 7Gy of 60Co y-irradiation
and allowed to grow for ten hours, which is the time needed for maximum G2
block formation in Hela cells. Pentoxifylline was then added to a final
concentration of 2 mM. At different time intervals thereafter, ranging from 2 -
25 hours, the Pentoxifylline treated and control samples were trypsinised,
fixed in 70% ethanol and stored at -20°C. After washing in PBS, cells were
resuspended in PBS containing 10l-lg of propidium iodide (Sigma) and 0.1%
RNase A. Samples were incubated for 20 minutes at 37°C prior to flow
cytometric analysis.
Immunocytochemistry
Fixed cells were prepared for multiparameter flow cytometry to simultaneously
measure total DNA content and cyclin B1 (Gong et ai, 1994) or p34cdC2
expression (Baroja et ai, 1996) as previously described. In short, the cells
were washed in PBS and treated with 0.25% Triton X-100 for 5 min. on ice.
After another wash in 5ml PBS, the cell suspension of 5x1 05cells/1 00 ui was
incubated overnight at 4°C in a 1:400 dilution of mouse monoclonal anti-cyclin
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B1 antibody (Pharmingen Clone GNS-1, San Diego, CA), or a purified
monoclonal anti_p34cdc2 antibody (clone HCDC1, ICN Biochemicals) in
PBS/1% Bovine Serum Albumine (BSA). The next morning, cells were
washed in PBS and incubated for 30 min at room temperature in a 1:40
dilution of fluorescein-isothiocyanate (FITC)-conjugated goat anti-mouse IgG
antibody (Sigma) in PBS/1% BSA. The cells were washed again,
resuspended in 10 ug/ml of propidium iodide and 0.1% RNase A in PBS, and
incubated for 20 min at room temperature prior to analysis. Negative controls
were prepared in a similar way, except that an isotype-specific antibody,
mouse IgG (Sigma), was used instead of the cyclin B1 or anti_p34cdc2
antibody.
Flow cytometry
To determine cyclin B1 or p34cdC2levels, samples were analysed on a Becton-
Dickinson (San Jose, CA) FACScan flow cytometer. Fluorescence data from
10 000 events were collected, stored and analysed using Lysis II software. To
determine the time of maximum G2 block, samples were analysed for red (PI)
fluorescence which was displayed as a DNA histogram. Markers placed at
the G2 boundaries served to estimate the G2 content for each time-point.
Cyclin B1 or p34cdC2expression, and DNA data, were displayed in dot plots of
red (PI) vs. green (FITC) fluorescence representing total cellular DNA content
and cyclin B1 or p34cdC2expression respectively. Cell doublets were gated
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out by using the doublet discrimination module. Determination of the G2
content was as described above. The fraction of cells expressing either cyclin
81 or p34cdC2was determined by gating only cells which displayed a positive
green (FITC) fluorescence. The threshold for FITC positive cells was defined
using the gate window set on the negative control sample which was prepared
with the isotype-specific antibody IgG1, on all the treated samples. All
experiments were repeated at least twice and generated identical trends.
Definition of cyclin 81/ G2, p34cdC2/G2 and cyclin 81/p34cdC2 ratios
The cyclin 81/ G2 and p34cdC2/G2ratios were calculated by comparing the
fraction of cells expressing either cyclin 81 or p34cdC2to the fraction of cells in
the G2 phase of the cell cycle for each post-irradiation time point. Cyclin 81/
p34cdC2ratios were obtained by dividing the 81/G2 ratios over the p34cdC2/G2
ratios.
Isolation of Hela nuclei:
Nuclei were obtained as described (Heussen et a', 1987). In short, cells from
exponentially growing cultures were washed once in "lysis" buffer consisting
of 10mM Tris-HCI, 10mM NaCl, 5mM MgCI2, pH 7.4. Cells were then
resuspended in ice-cold lysis buffer at 1-3x106 cells/ml and allowed to swell
for about 15-20 minutes on ice. Lysis of cells wer.e completed by the dropwise
addition of 10% (v/v) nonidet- P40 (Shell Chemical Co) in lysis buffer to a final
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concentration of 0.5% (v/v). During this step, the sample was vortexed
vigorously. Released nuclei were sedimented at 300g for 5 minutes in a
swing bucket rotor and resuspended gently by stepwise addition of small
volumes of phosphate-buffered saline, pH 7.4, and gentle vortexing, essential
to prevent clumping. The isolation of nuclei was confirmed by microscopy,
and the sample was then subjected to the normal staining procedure for cyclin
81.
Data evaluation
All experiments were repeated at least three times, and the data are given as
a mean ± standard deviation (SO) or standard error margin (SEM) for the
independent experiments. Statistical analysis and data fitting were performed
by means of the GraphPad Prism (GraphPad Software, San Diego, USA)
computer program. A two-sided t test was used to compare the means
between sample groups.
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Chapter 4
Results
Drug toxicity
The TD50 of pentoxifylline (toxic dose causing 50% cell death) was found to be
6.0, 3.2, 5.6 and 4.1 mM for Be11, MeWo, 4197 and 4451 cells respectively
(data not shown). A sub-toxic dose of 2mM pentoxifylline was used in all four
cell lines in subsequent experiments.
G2 block expression
The G2 block maximum in response to a single dose of 7 Gy was found to be
16, 18, 12 and 24 hours for Be11, MeWo, 4197 and 4451 respectively. Fig. 8
shows examples of G2 block abrogation by pentoxifylline in the 4197 (Fig.
8A) and 4451 (Fig. 8B) sec cell lines. Similar trends were seen in the Be11
and MeWo melanoma cell lines (data not shown). Both TP53 wild type and
mutant cell lines respond to irradiation by an increase in the G2 population. In
mutant cells G2 levels reach 60-80% (Fig 8B) and are higher than in TP53
wild type cells (Fig 8A) where G2 levels reach only 40-50%, the remainder of
cells being blocked in G1. The time of recovery from the G2 block in
irradiated cells in the absence of pentoxifylline is 40-60 hours. In the
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Figure 8
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DNA histograms showing the influence of 7 Gy of irradiation,
and 7 Gy of irradiation plus pentoxifylline added at maximum G2
block, on the distribution of cells in G1 and G2 cell cycle phases
at various post-irradiation times in TP53 wildtype 4197 sec cells
(A) and TP53 mutant 4451 sec cells (8).
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presence of 2 mM pentoxifylline, the G2 population is reduced to control
values in approximately 8 hours (Fig. 8).
Cellular radiotoxicity
Cell survival after doses of 0-10 Gy 60Co y-irradiation was measured for
irradiation alone, and for irradiation in the presence of pentoxifylline. Figs. 9
A-D show survival curves obtained from colony assay data in Be11, MeWo,
4197 and 4451 cells respectively. Survival curves were fitted by the linear-
quadratic equation, -InS = aD+~D2. MeWo, 4197 and 4451 cells show
similar radiosensitivities with SF2 values of 0.35, 0.37 and 0.36 respectively.
The Be11 cell line emerges as the most radioresistant, showing an SF2 value
of 0.66. There is some variation between our survival data and the original
data reported by Zolzer et al (1995). This can possibly be attributed to the
higher passage numbers used in our laboratory and the experimental design
of Zolzer et al using X-rays. Pentoxifylline markedly increases cell death in
the two TP53 mutant cell lines MeWo (p = 0.015) and 4451 (p < 0.0001)
(Fig.9, B and D), while it has no effect on survival in the two TP53 wild type
cell lines Be11 (p = 0.768) and 4197 (p = 0.963) (Fig.9, A and C). The
radiotoxicity enhancement factors (REF's) in the presence of pentoxifylline are
given in Table 1. Survival fractions were calculated for doses ranging from 2-
10 Gy to ensure comparability with the dose of 7 Gy given to cells under
conditions of G2 block abrogation. At 2,4,6 and 8 Gy of 60Co y-irradiation,
pentoxifylline enhances the radiotoxicity by factors of 1.2, 1.64, 4.2 and 14.5
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Survival curves of 8e11 (A) and MeWo (8) melanoma and 4197 (C) and 4451
(D) SCC cells following irradiation. Pentoxifylline at the subtoxic dose of 2 mM
was added to the medium immediately prior to irradiation. Cell survival was
measured by the colony assay, and data were fitted to the linear quadratic
equation, after irradiation alone (0-0) and irradiation in the presence of
pentoxifylline (.-.).
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respectively in the 4451 TP53 mutant SCC cell line. In the 4197 TP53 wild
type SCC cells, the drug has no influence on radiotoxicity and enhancement
factors were found to be close to 1 for the same dose range. In the TP53
mutant MeWo melanoma cell line, pentoxifylline enhances radiotoxicity by
factors of 1.29, 1.66, 1.88, 2.0 and 3 at doses of 2,4,6,8, and 10 Gy 60Co y-
irradiation respectively. No enhancement of radiotoxicity by pentoxifylline is
seen in the TP53 wild type 8e11 cells over the same dose range. When
pentoxifylline was added at the G2 maximum after a single dose of 7 Gy, the
drug was found to markedly reduce the duration of the G2 block from
approximately 20-40 hours to approximately 8 hours (Fig. 8). However, under
these conditions there is no influence on radiotoxicity. This is evident from the
REF* values (SF7) which are close to 1 for both the TP53 wild type cell lines
8e11 and 4197, and the TP53 mutant cell lines MeWo and 4451 (Table 1).
DNA repair
Dose response curves representing initial DNA damage, and residual DNA
dsb damage after 2h and 20h repair times for the dose range 10-100 Gy are
shown in Figure 10. Fractions of DNA released (Frei) were plotted against
dose, and the area under each curve (AUC) was calculated to compare initial
DNA dsb's to the residual unrepaired dsb's after 2h and 20 h of repair in the
presence or absence of pentoxifylline. These results are summarised in
Table 2. The differences between residual damage after 2h in the presence
or absence of pentoxifylline were significant in 8e11, MeWo and 4197
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Table 1
Radiotoxicity enhancement factors (REF) for a range of irradiation doses
calculated from cell survival fractions. Pentoxifylline was added to the growth
medium immediately prior to irradiation.
8e11 MeWo 4197 4451
SF2 1.13±0.07 1.29±0.03 O.97±0.02 1.2±0.Q3
SF4 O.93± 0.13 1.66±0.1 O.97±0.04 1.64±0.03
SF6 1.09±0.27 1.88±0.06 1.06±0.09 4.2±0.47
SF7
.
1.01±0.02 1.01±0.02 1.1±0.041.1±0.05
SFB O.82±0.44 2.0±0.59 1.0±0.30 14.5±1.04
SFlO 1.2±0.22 3.0±0.63
*REF (SF7) values were calculated from cell survival fractions by adding the
drug at the G2 maximum after a single dose of 7 Gy.
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Figure 10
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CFGE data showing fractions of DNA released for the dose range of 0-100 Gy in
8e11 (A), MeWo (8), 4197 (C) and 4451 (D) cells, as determined by fluorescent
densitometry of Et8r stained gels. Area under the curve (AUC) was calculated for
each dose response curve and are given in Table 2.
+-+ Initial DNA damage measured immediately after irradiation .
• -. Residual DNA damage measured after 2 hrs. repair incubation at 37°C .
.A.-.A. Residual DNA damage measured after 2 hrs. repair incubation at 3rC in the
presence of pentoxifylline.
0-0 Residual DNA damage measured after 20 hrs. repair incubation at 37°C.
x-x Residual DNA damage measured after 20 hrs repair incubation at 3rC in
presence of pentoxifylline
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Table 2
Areas under the dose-response curves (AUC) calculated from fractions of
DNA released against irradiation dose (Fig. 4 data) for 0, 2 and 20 hrs. after
irradiation over a dose range of 0-100 Gy.
8e11 MeWo 4197 4451
Initial DNA
damage
54.45 49.84 42.63 40.13
2 hrs. repair 17.29 19.30 12.82 12.43
2 hrs. repair
+pentoxifyll ine
25.13 27.40 19.53 18.46
20 hrs repair 1.53 9.5 3.97 7.16
20 hrs. repair
+pentoxifyll ine
2.17 22.5 7.52 13.45
T-test analyses of differences between AUC's after 2h in the presence or
absence of pentoxifylline showed p-values of 0.022, 0.049, 0.008 and 0.122
for 8e11, MeWo, 4197 and 4451 respectively. Similar analyses of 20h data
showed p-values of 0.048,0.029,0.021 and 0.049 for 8e11, MeWo, 4197 and
4451 respectively.
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(p = 0.022, 0.049 and 0.008 respectively). The 4451 did not show a
significant difference after 2h repair (p = 0.122). However, after 20h repair
incubation, significant differences were seen between pentoxifylline treated
and control samples in all four cell lines (p = 0.048, 0.029, 0.021 and 0.049
for 8e11, MeWo, 4197 and 4451 respectively).
To assess the quality of dsb repair in untreated cells, ratios of the AUC's
representing initial damage vs. residual damage after 2h and after 20h were
calculated. These ratios are summarised in Table 3. After 2 h of repair, the
8e11, MeWo, 4197 and 4451 cells showed repair ratios of 3.15, 2.58, 3.33
and 3.23 respectively. In the presence of pentoxifylline, these ratios were
reduced to 2.17,1.82,2.18 and 2.17 in 8e11, MeWo, 4197 and 4451
respectively. The 20h control repair ratios were found to be 35.59, 5.25,
10.74 and 5.6 in 8e11, MeWo, 4197 and 4451 respectively. In the presence
of pentoxifylline these ratios were reduced to 25.09, 2.22, 5.67 and 2.98 in
8e11, MeWo, 4197 and 4451 respectively. These repair ratios (Table 3)
were used to calculate repair inhibition factors (RIF's) for the two repair
incubation periods (Table 4). After 2 h of repair in the presence of
pentoxifylline, RIF's were found to be 1.45, 1.42, 1.52 and 1.49 in 8e11,
MeWo, 4197 and 4451 respectively. The 20h repair data showed RIF's of
1.42,2.37,1.89 and 1.88 in 8e11, MeWo, 4197 and 4451 respectively (Table
4).
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Table 3
Ratios of initial vs. residual DNA damage derived from AUC data (Table 2) for
various repair times in the absence or presence of pentoxifylline.
8e11 MeWo 4197 4451
2 hrs. repair 3.15 2.58 3.33 3.23
2 hrs. repair 2.17 1.82 2.18 2.17
+pentoxifylline
20 hrs. repair 35.59 5.25 10.74 5.60
20 hrs. repair 25.09 2.22 5.67 2.98
+pentoxifyll ine
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Table 4
Repair inhibition factors (RIF's) as calculated from repair ratios (Table 3) in
the absence and presence of pentoxifylline.
8e11 MeWo 4197 4451
RIF 2 hrs. 1.45 1.42 1.52 1.49
RIF 20 hrs. 1.42 2.37 1.89 1.88
51
Stellenbosch University http://scholar.sun.ac.za
Apoptosis in TP53 mutant melanoma and sec cell lines:
The influence of pentoxifylline on irradiation-induced apoptosis was assessed
in the two TP53 mutant MeWo and 4451 cell lines which show dose
modification factors of up to 3 and 14.5 respectively (Table 5). Control levels
of apoptotic fractions were 8 ± 1.2% and 3 ± 0.5% in MeWo and 4451 cells
respectively. Twenty-four hrs. after a single dose of 7 Gy, these fractions
increased to 27 ± 9 % and 34% ± 11 in MeWo and 4451 cells respectively.
Addition of pentoxifylline immediately prior to irradiation under the same
conditions lead to apoptotic fractions of 27 ± 12% and 35 ± 15% in MeWo and
4451 cells respectively. Identical trends were seen in samples analysed after
48h (Table 5). The rather large error margins are attributed to the fact that the
scraping of adherent cells causes membrane damage. However, the Annexin
V method was used since it allows for the analysis of a large number of cells
and it distinguishes between apoptotic cells and necrotic cells or debris. The
data trends were confirmed by analysis of a sub-G1 peak in DNA flow
histograms (data not shown).
Apoptosis in Jurkat J5 cells:
To investigate the possibility of a cell type specific effect, the influence of
pentoxifylline on radiation-induced apoptosis was also measured in the Jurkat
J5 lymphocytic leukemia cells (Fig.11). Pentoxifylline was added at irradiation
and the influence on apoptosis measured by Annexin V (Fig. 11A) and sub-
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Table 5
Effect of pentoxifylline on apoptotic fractions (% apoptosis) in irradiated
TP53 mutant cells. A single dose of 7 Gy 6°Co-y-irradiation was used.
Cell line Time Control Irradiation
only
Irradiation
+
pentoxifyll ine
MeWo 24 hrs 8 ± 1.2 27 ±9 27 ± 12
48 hrs 8 ± 1.2 31 ± 8 27 ±9
4451 24 hrs 3 ±0.5 34 ± 11 35 ± 15
48 hrs 3 ±0.5 40 ±3 40 ± 12
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Figure 11
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The influence of pentoxifylline on radiation-induced apoptosis as
measured by the Annexin V method (A) or by measuring sub-G1
peaks by flow cytometry (8). Cells were irradiated with 7Gy of ooCo-
rays in the presence of the drug.
54
Stellenbosch University http://scholar.sun.ac.za
G1 peaks (Fig. 118) after 24h and 48h. Similar trends are observed for both
methods. Pentoxifylline increases irradiation-induced apoptosis in these cells
from approximately 26.4 ± 4.5% to 39.8 ± 5% after 24h, and from
approximately 34.5 ± 5.5% to 50.8 ± 8.5% after 48h. These values are the
means calculated from the two methods, corrected for control apoptosis at
24h and 48h, and show significant differences between apoptosis in the
presence of pentoxifylline and with irradiation alone. Pentoxifylline alone had
virtually no effect on apoptosis over 48h in this cell line, as indicated by the
apoptotic fractions of approximately 15% in the presence of pentoxifylline
alone (Fig 11A and 8).
Cyclin 81 expression in Hela cells
In Hela cells (Fig. 12A), the radiation induced G2 cell cycle block reaches a
maximum at 10 hours after a single dose of 7 Gy (Fig. 128). From the dot-
plot of red (Pil total DNA) vs. green (FITC I cyclin 81) fluorescence, it is clear
that cyclin 81 is only synthesised in late S-phase and reaches maximum
expression in G2 (Fig. 13A). No cyclin 81 is seen in G1-phase because of the
rapid degradation of this protein in early mitosis. As the cells accumulate in
G2, there is a concominant rise in cyclin 81 content (Fig. 138).
The increase in the G2 fraction of the cell cycle during expression of the block
and the decrease of this fraction as the block resolves over 35 hours are
shown in Fig. 14 (solid line). Addition of 2 mM pentoxifylline at 10 hours after
irradiation, when the G2 delay had reached a maximum, rapidly abrogates the
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Figure 12
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Flow cytometric histogram of the total DNA content of Hela cells, indicating
the normal cell cycle distribution (A) and the maximum formation of the G2
cell cycle delay at 10-12 hours after irradiation (8).
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Dot plots of green fluorescence (FITC) on the vertical scale vs. red
fluorescence (PI) on the horizontal scale, representing cyclin 81 and total
DNA content respectively, indicating the G2-phase specific expression of
cyclin 81 in Hela cells before (A) and 10 hours after irradiation (8).
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Figure 14
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pentoxifylline addition.
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G2 delay and cells return into cycle (Fig. 14, dashed line). Over the same
time window, cyclin 81 content rises and parallels the increase of the G2-
phase fraction after irradiation (Fig. 15 - solid line), and the decrease after
pentoxifylline treatment (Fig. 15 - dashed line).
When the ratio of cyclin 81 fraction vs. G2 fraction is plotted, it is seen that
cyclin 81 expression actually decreases at the induction of the G2 block, and
stays below control levels for the entire duration of the G2 block (Fig. 16 -
solid line). When pentoxifylline is added at 10 hours after irradiation, this ratio
is rapidly restored to the level seen in the unirradiated control sample (Fig. 16
- dashed line).
p34CdC2 expression in Hela cells
From the dot-plot of red (PI/DNA content) vs. green (FITC/p34) fluorescence it
is evident that, unlike cyclin 81, p34cdC2is not uniquely expressed in the G2
phase of the cell cycle, but also exists in the G1 phase (Fig. 17A). However, it
is predominantly expressed in the G2 phase during G2 arrest (Fig. 178).
Similar to cyclin 81, the expression of p34cdC2increases after irradiation, at the
formation of the G2 block, and drops after pentoxifylline treatment (Fig 18).
When the ratios of p34cdC2to G2 fraction are plotted over time, an over-
expression of p34cdC2during G2 arrest becomes evident as the ratio increases
from 0.1 in controls to approximately 0.48 in irradiated cells. Pentoxifylline
treatment reduces the p34cdC2expression to the control level of 0.1 (Fig. 19).
Fig. 16 shows the cyclin 81/G2 ratios for similar dose and time points in Hela.
Since cyclin 81 and p34cdC2act in concert we also plotted the cyclin 81/p34cdC2
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Figure 15
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Figure 17
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Dot plots of green fluorescence (FITC) on the vertical scale vs. red fluorescence
(PI) on the horizontal scale, representing p34cdC2 content and total DNA content,
respectively. Percentages of cells expressing p34cdC2 are indicated for Hela cells
in the G1 and G2 phases, before (A) and at maximum G2 block (8).
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Figure 18
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Increase of the p34cdC2 content which parallels the rise of the G2 fraction after
irradiation (. ), and the abrogation of the block by Pentoxifylline (.) over
36h following irradiation in Hela cells. Arrow indicates the addition of
pentoxifylline.
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Figure 19
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p34CdC2/G2 ratios plotted over a 36h time period after irradiation in Hela
cells. This ratio increases after irradiation ( A), but is reduced to control
levels within Bh after the addition of pentoxifylline (. ). Arrow indicates
the addition of pentoxifylline.
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ratios (see definition in material and method section). Fig. 20 shows that the
G2 maximum is associated with a very low cyclin B1/p34cdC2 ratio which
gradually increases as the cells recover from the G2 block and enter mitosis
after 40 h. Pentoxifylline added at the maximum G2 block rapidly restores the
cyclin B1/p34cdC2 ratio over a very narrow time window, which reaches the
control value after -7 h. Abrogation of the G2 block thus is associated with a
rapid restoration of the critical cyclin B1/p34cdC2 ratio.
Subcellular location of MPF
In order to study the influence of pentoxifylline on subcellular translocation of
the cyclin/cdk complex, we compared cyclin B1 expression in isolated Hela
nuclei and whole Hela cells. Addition of pentoxifylline to whole cells at the
time of maximum G2 block results in a rapid restoration of the control cyclin
B1/G2 ratio within -7 h which remains at control levels for up to 35 h. In the
absence of pentoxifylline, these ratios were not fully restored within 35 h,
similar to the trends shown in Fig. 16. In nuclei (Fig. 21) the G2 block
abrogation by pentoxifylline induces a sharp drop in cyclin B1 expression after
18h. This suggests that cyclin B1 crosses the nuclear membrane after G2
block abrogation and reenters the cytoplasm where it is probably degraded by
ubiquitin mediated proteolysis (Pines, 1999). Identical data trends were
observed in A549 human lung carcinoma cells (not shown).
65
Stellenbosch University http://scholar.sun.ac.za
Figure 20
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Ratios of cyclin 81/ p34cdC2 plotted over 36h after irradiation in Hela.
During the formation of the radiation-induced G2 block, this ratio is
drastically reduced, and recovers slowly during the normal recovery
of the cell cycle (&). After the addition of pentoxifylline at maximum
G2 block (arrow), this ratio is rapidly restored to control levels within
approximately 6h ( • ).
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Hours after irradiation
Decrease in the cyclin 81/ G2 ratio following irradiation in
isolated Hela nuclei (~ ), and rapid recovery to control
ratios in 6-8 h in the presence of pentoxifylline ( • ) as
shown before for whole cells (Fig. 16). After G2 block
abrogation, cyclin 81 is exported from the nucleus as
indicated by the sharp decrease in cyclin 81/G2 ratios
between 18h and 36h. Arrow shows pentoxifylline addition.
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Chapter 5
Discussion
The enhancement of radiotoxicity by caffeine and pentoxifylline has been
attributed to a strong inhibition of the damage-induced G2 cell cycle
checkpoint (Russell et al, 1995, Li et al 1998). However, no experimental
evidence exists to support this conclusion. Data presented here show that the
presence of pentoxifylline at the time of irradiation significantly enhances
radiotoxicity in the two TP53 mutant cell lines MeWo and 4451 by factors of
up to 14.5 (Fig 9, 8 and D). No enhancement of radiotoxicity is seen in the
TP53 wild type cell lines (Fig. 9, A and C). This is in agreement with previous
reports on the methylxanthine-induced radiosensitisation in TP53 mutant and
deficient cells (Powell et al, 1995; Russell et al, 1995; Russell et al, 1996; Li et
al, 1998; Lietal, 1999; Fanetal, 1995).
When cells were irradiated with a single dose of 7 Gy, and pentoxifylline was
added at the time of maximum G2 block expression, no enhancement of
radiotoxicity, measured as a reduction of clonogens, was seen in any of the
four cell lines. It would thus seem that the early induction of mitosis by
pentoxifylline through G2 cell cycle block abrogation cannot be solely
responsible for the enhancement of radiotoxicity seen in TP53 mutant cells.
That G2 block abrogation indeed induces mitosis has been demonstrated by
measurements of histone H3-phosphorylation levels in the 8e11, MeWo, 4197
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and 4451 cell lines. These levels showed a marked increase immediately
after G2 block abrogation, which is an indication that G2 cells enter mitosis (A.
Binder, personal communication; Juan et al 1998; Juan et al, 1999).
The possibility that the enhancement of radiotoxicity in the TP53 mutant cell
lines MeWo and 4451 is due to increased apoptosis was considered. Our
experimental data show no significant differences between apoptotic fractions
as measured by Annexin-V binding (Table 5). In the two TP53 mutant cell
lines, MeWo and 4451, which exhibit irradiation-induced apoptosis and show
a significant increase of radiotoxicity, the apoptotic yield is not influenced by
pentoxifylline. This conclusion is in agreement with recent data on caffeine,
which demonstrate that the mechanism of action of this drug as a
radiosensitiser is not dependent on G2 block abrogation or apoptosis
induction in human bladder cancer cells (Ribeiro et ai, 1999).
It is well documented that many cell types, especially of haematopoetic origin,
mainly die via apoptotic pathways following DNA damage, whereas other cell
types are more resistant to apoptosis and die instead by necrosis, mitotic
death or terminal cell cycle arrest (Blank et ai, 1997). Mitotic death can be
defined as a loss of clonogenic survival from the formation of cells that have
lost the ability to divide, but remain metabolically active (Bernhard et ai, 1996).
These cells may undergo apoptosis at a later stage or die by a pathway
involving the formation of micronuclei. The possibility that the effect of
pentoxifylline on apoptosis may be dependent on cell type was investigated
by measuring the influence on radiation-induced apoptosis in Jurkat J5
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lymphocytic leukemia cells. This cell line has TP53-null status and shows no
G1 arrest following irradiation. A strong G2 block is induced which reaches a
maximum approximately 18h post-irradiation (data not shown). The
significant increase in apoptosis observed in these cells following radiation
exposure in the presence of pentoxifylline as compared to radiation alone
(Fig. 11) confirms that the drug can indeed increase apoptosis in certain cell
types. Although the influence of pentoxifylline on radiotoxicity in Jurkat cells
could not be measured by the clonogenic assay, due to their growth in
suspension, it is presumed that the observed increase in apoptosis was
accompanied by radiosensitisation, as with other cells lacking TP53
expression. It seems likely that the increase in apoptosis by pentoxifylline
may be restricted to cell types such as those from haematopoetic origin, in
which the apoptotic pathways are strongly expressed. This conclusion is
however at variance with a study showing caffeine enhancement of radiation-
induced apoptosis in Hela cells, which predominantly undergo mitotic death
(Bernhard et ai, 1996). The reasons for the apparent cell type specificity of
apoptosis induction by methylxanthines therefore must be considered as
unresolved. The pathways involved in the induction of apoptosis by
pentoxifylline is also unknown, but in the Hela and Jurkat cell lines must be
TP53-independent, as neither of these lines express wild type TP53.
DNA repair consists of a fast component «4h) during which the bulk of DNA
is repaired, and a slow component which is completed 16-24 hrs after
irradiation (Dikomey et ai, 1998). In the four cancer cell lines studied here,
the G2 block maximum is reached 12-20 hours after irradiation, and an
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additional 20-40 hours are required for the G2 block to resolve in the absence
of pentoxifylline. While G2 checkpoint activation and repair may be
interrelated, a definite requirement of a G2 block as a repair facilitator is not
obvious. It has been suggested that pentoxifylline inhibits early repair events
(Fingert et ai, 1992). Pentoxifylline has been found to inhibit repair of UV-
induced DNA damage in hamster cells (Link et ai, 1996). For human cells no
data exist on the role of pentoxifylline in repair, although caffeine has been
found to inhibit repair-replication after UV-irradiation in human xeroderma
pigmentosum cells (Link et ai, 1995). Here we demonstrate by constant field
gel electrophoresis (CFGE) that pentoxifylline significantly increases the
remaining unrepaired irradiation-induced DNA dsb's after a 20h repair period
in four human tumour cell lines.
A comparison of residual dsb's after 20h between untreated controls, reveal
differences between the four cell lines which correspond with radiosensitivity
(Table 3). No significant variation was observed in the initial DNA damage.
This is in agreement with other reports showing a correlation between
radiosensitivity and repair of dsb's (Schwartz et ai, 1988; Whitaker et ai, 1995;
Dikomey et ai, 1998), but contrasts with studies finding no relationship
between repair and radiosensitivity (Smeets et al 1993; Olive et ai, 1994), and
others showing large differences in the induction of dsb (Zaffaroni et ai, 1994;
Ruiz de Almodovar et ai, 1994). The reason for these discrepancies is not
known at present, and may require more sensitive repair assays. In this study
and others, differences in repair ratios only became evident after high doses
(> 30 Gy). The control 20h repair ratios in the two TP53 wild type cell lines
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8e11 and 4197 are higher compared to those in the two mutant cell lines,
indicating a better repair capacity for the TP53 wild type cell lines.
That DNA repair is also not the major mechanism involved in the
radiosensitisation by pentoxifylline is clear from the fact that the drug
significantly inhibits repair in all four cell lines, but enhances radiotoxicity only
in the two mutant cell lines. In the TP53 mutant MeWo melanoma cell line,
repair inhibition at 20h shows an RIF of 2.37. In the TP53 wild type 8e11
melanoma cell line, the 20h RIF was found to be 1.42 which is considerably
lower. In MeWo cells, the 20h repair data furthermore indicate that repair
inhibition by pentoxifylline is statistically signficant (p = 0.029), while the
corresponding measurements in 8e11 cells only show borderline significance
(p = 0.048). MeWo cells exhibit an REF of 3 indicating a relatively strong
radiosensitisation effect, whereas 8e11 shows an REF close to 1.0 indicating
no radiosensitisation. In the melanoma cell lines, repair inhibition thus
strongly correlates with the enhancement of radiotoxicity and also
corresponds with TP53 status and radiosensitivity (Table 1). However, this
correlation is not apparent in the sec cell lines, where no simple relationship
between radiation-induced dsb's and cell survival exists. This is highlighted
by the fact that in the 4451 sec cell line, which undergoes the largest
radiosensitisation, the 2h repair in the presence of pentoxifylline is not
significantly different from controls (p = 0.122). After 20h of repair, the 4451
cells show borderline significance of repair inhibition (p = 0.049). In the 4197
sec cell line, which does not undergo radiosensitisation by pentoxifylline,
repair is significantly influenced by pentoxifylline at 2h and 20h (p = 0.008 and
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p = 0.021 respectively). A lack of correlation between DNA dsb's and cell
survival has previously been reported in 8 SCC and 2 Iymphoblastoid cell
lines, where G2 block abrogation has been found to lead to a higher
frequency of unrejoined chromosome breaks, but there was no correlation
between G2 phase duration and radiosensitivity (Schwartz et ai, 1996).
Another study on two human SCC cell lines revealed a poor correlation
between dsb's and cell death, and led to the suggestion that the inherent
radiosensitivity in these cells may be influenced by misrepair and damage
tolerance (Smeets et ai, 1994). More studies on SCC cells are needed to
clarify these observations. In the TP53 wild type 8e11 and 4197 cells, which
show significant DNA repair inhibition by pentoxifylline, the poor
radiosensitisation and better survival may possibly be attributed to the fact
that these cells show a strong G1 cell cycle block (Fig. 8). DNA repair during
the G1 cell cycle arrest is mediated by the GADD45 protein. GADD45 is
induced in TP53 wild type cells by doses as low as 0.5 Gy, and has been
shown to bind to proliferating cell nuclear antigen (PCNA) and to stimulate
DNA excision repair in vitro (Maity et ai, 1997). Whether the G1 block or this
repair pathway plays a role in the survival of these SCC cells however
remains to be established.
It is demonstrated here that, in certain cell types, pentoxifylline enhances
radiotoxicity by inhibiting DNA dsb repair. The assumption that G2 block
abrogation is the main mechanism by which radiosensitisation is
accomplished (O'Connor et ai, 1996; Husain et ai, 1998; Li et ai, 1998), could
not be corroborated by these data. In the melanoma and SCC cell lines used
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here, induction of apoptosis also does not play a role. From these
experiments it is clear that radiosensitisation by pentoxifylline should be
evaluated separately from G2 block abrogation. In the Be11 and MeWo
melanoma cell lines, repair inhibition correlates strongly with
radiosensitisation and TP53 status. However, in the 4197 and 4451 sec
cells, the strong radiosensitisation effect seen in the mutant cell line is not
reflected by repair inhibition. The possibility that repair inhibition and G2 block
abrogation act in concert, or that other mechanisms are involved in the
enhancement of radiotoxicity can therefore not be excluded. The different
behaviour of melanoma and sec cell lines indicates that the mechanism by
which pentoxifylline sensitises cells to ionising radiation is cell type specific.
The mechanisms by which pentoxifylline influences repair also remains to be
elucidated. Since TP53 mutant cancer cells generally show enhanced
radiosensitisation, sparing of TP53 proficient normal tissue by pentoxifylline
treatment is a real possibility.
It has been demonstrated elsewhere that suppression of the G2 checkpoint by
pentoxifylline is an effective strategy whereby TP53 defective cells can be
targeted for destruction by a second irradiation or chemotherapeutic insult
(Wang et aI, 1996; Binder et al, 2000). The molecular mechanisms involved
in G2 block abrogation by pentoxifylline has not been elucidated, and is of
critical importance for a better understanding of the potential clinical
application of this drug as a radio- or chemo-sensitiser. The possibility of a
modulation of the expression levels and sub-cellular location of the two
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components of the mitosis promoting factor (MPF), cyclin 81 and p34cdC2 has
therefore been investigated.
The simultaneous measurement of total DNA content and cyclin 81
expression allows for a quick and relatively easy way of directly correlating
cyclin 81 expression to cell cycle phase. Most previous studies have
employed synchronised cells and the more laborious western blotting method
to analyse for cyclin 81 expression (Muschel et a/1991, 8ernhard et al. 1994
b, Muschel, Zhang and McKenna, 1993) and thus could not correlate cyclin
expression and DNA content directly. Other authors have however indicated
the value of flow cytometric analysis of asynchronous populations for this type
of study (Sherwood et al. 1994). Flow cytometric results reported here
revealed that cyclin 81 levels in Hela cells begin rising in late S-phase and
reach a maximum in G2 phase. No cyclin 81 expression was seen in other
cell cycle phases. This confirms that Hela cells do not exert unscheduled
cyclin expression often seen in other tumour cells (Gong et al. 1994 b). The
tendency of synchronised cells to show an unscheduled expression of cyclins
and other cellular proteins has been demonstrated (Gong et al. 1995). For this
reason we opted to use asynchronously growing undisturbed cell cultures.
My results demonstrate that the down-regulation of cyclin 81 expression plays
a role in the formation of the radiation induced cell cycle delay in the G2-
phase. This suppression of cyclin 81 expression probably prevents the
optimum formation of the MPF which is essential for cells to cross the
threshold from G2 into mitosis. These conclusions are in agreement with
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other studies on synchronised cells which have relied on different methods of
analysing cyclin expression after exposure to irradiation (Muschel et al. 1991,
8ernhard et al. 1994 a) and after treatment with DNA damaging agents like
camptothecin, etoposide and nitrogen mustard (Maity et al. 1996). A dose-
dependency of cyclin 81 suppression observed by Villa et al (1996) cannot be
refuted since we used a constant dose of 7 Gy throughout. My finding that an
increase in cyclin 81 expression is concominant with the increase in G2
content is in agreement with data from Smeets et al (1994). However, the
percentage of cells in G2-phase in asynchronous cells is small (10-15%) and
virtually all the cyclin 81 originates from this G2 fraction. When these cells are
irradiated, the G2 levels rise to approximately 80% and this explains the
massive rise in cyclin 81 (Figure 2). However, when the cyclin 81 content is
expressed in relation to the G2 content, it is seen that irradiation in fact
reduces the 8 1/G2 ratio to below control levels. When we followed this ratio at
regular intervals over 25 hours, we found that it slowly returns to normal,
concominant with the recovery of the cell cycle. The approach used here
solves two problems: it eliminates the need for synchronised cells, and it puts
the cyclin 81 levels in perspective to the G2 fraction.
These results demonstrate that abrogation of the G2 block by Pentoxifylline
restores the cyclin 81/G2 ratio to control levels within 6-8 hours after addition
of the drug. This is in agreement with other studies on the influence of
Pentoxifylline (O'Connor et al. 1993) and Caffeine (8ernhard et al. 1994 b) on
cyclin 81 expression in nitrogen mustard treated and irradiated cells
respectively. The induction of cyclin 81 expression by Pentoxifylline in G2
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blocked cells resembles data on a dexamethasone-inducible promotor which
abrogates the G2 block (Kao et al. 1997). It is therefore concluded that the
level of cyclin 81 is indeed a controlling factor in the length of the G2 delay.
Formation of the MPF by the availibility of sufficient quantities of cyclin 81 and
p34cdC2 is only part of the mechanism by which cells recognise DNA damage
and control the cell cycle at the G2 checkpoint. This complex has to be
activated by different kinases and phosphatases in order to be functional
(reviewed by Murray 1992). The decrease in cyclin 81 expression below
control levels after induction of the G2 block is rather small and hence may
not be solely responsible for the formation of the G2 delay. The move of
cyclin 81 to the cell nucleus may also be an important event (Kakino et al.
1996) and has been shown to drop sharply after irradiation (Smeets et al.
1994). Various studies on the expression of the p34cdC2 protein (Lock 1992,
Lock and Ross, 1990), the activity of the MPF as regulated by P34cdC2
phosphorylation (Ling et al. 1996, Orlandi et al. 1996) and the localisation of
cyclin 81 (David-Pfeuty and Nouvain-Dooghe 1996, Li, Meyer and Donoghue
1997) and p34cdC2 (Cohen-Johnathan et al. 1997) have indicated other levels
of control at the G2 checkpoint. Answers to the role of cdc25 phosphatase
and mik1/wee1 kinase activity which plays a crucial role in the activation of
the MPF may further help to unravel the complexities of the G2 delay
mechanism.
Expression levels of the p34cdC2 cyclin dependent kinase was therefore
measured in a similar way. These results show that irradiation induced DNA
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damage also has a profound influence on the expression of p34cdC2.The rise
in p34cdC2expression (Fig. 188) is in agreement with results from Smeets et a/
(1994) who reported an increase of the hyperphosphorylated inactive form of
p34cdC2based on Western blots. Since G2 block formation, as with the cyclin
81 measurements, is associated with an increase in the number of G2 cells
and in the level of p34cdC2(Fig. 18) we decided to use the p34/G2 ratios to
assess changes of p34cdC2expression relative to the number of cells in G2
(Fig. 19). G2, p34cdC2and the ratio of p34cdC2/G2show a maximum at 10-14
hours after irradiation. Addition of pentoxifylline rapidly restores the
p34cdC2/G2ratio to the control values within 8 hours (Fig. 19). It therefore can
be safely concluded that p34cdC2is upregulated in response to DNA damage.
It is possible that this upregulation results in the expression of a
hyperphosphorylated, inactive form for the duration of the G2 block (Smeets et
al, 1994).
It appears that the existence of the two MPF components enhances the
sensitivity of the complex to small changes of the concentration of either
constituent. This would result in an "all-or-nothing" reaction resembling a
switch. The required changes in substrate concentrations do not follow the
normal Michaelis-Menten enzyme kinetics but are characterised by an
ultrasensitive response (Ferrel and Machlader, 1998; Koshland, 1998). In
ultrasensitive kinetics the maximum velocity is achieved by a 1-4 fold change
in substrate concentration, rather than the 80-fold change observed in normal
Michaelis-Menten kinetics (Koshiand, 1998). The switch-like response has
previously been attributed to the translocation efficiency of the cyclin/cdk
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complex (Ferrel 1998, TI8S). My data suggest that changes in the
concentration of cyclin 81 and p34cdC2 indeed act in concert, resembling an
ultrasensitive switch (Fig. 20). Translocation of the complex accross the
nuclear membrane would further ensure rapid control of mitotic entry. The
change of the cyclin 81/p34cdc2 ratios closely resembles other ultrasensitive
reactions e.g. the cooperativity of O2 binding by hemoglobin (Koshiand, 1998).
These experiments only assess the expression of the required amounts of
cyclin 81 and p34cdC2 and do not address the additional activation expected
from MPF phosphorylation. It is suggested here that the restoration of the
control ratio of cyclin 81/p34cdc2 expression by pentoxifylline forms a crucial
part of the mechanism of action of this G2 block abrogator.
When the influence of block abrogation on the subcellular location of cyclin 81
was assessed, no significant differences were seen between cyclin 81
expression in whole cells and in nuclei, although overall levels seem
consistently higher in whole cells. A sharp increase in cyclin 81 expression
occurs in nuclei during G2 block abrogation by pentoxifylline (Fig. 21).
Subsequently (after -8 h) the 81 levels in nuclei falls sharply to even below
the levels of irradiated control cells. This is most likely followed by ubiquitin
mediated proteolysis of the cyclin 81 required for exit from mitosis (King et aI,
1996). It thus appears that pentoxifylline prompts mitotic entry and also exit
from mitosis.
These data suggest that G2-block abrogation by pentoxifylline does not result
in cell cycle perturbations and the uncoupling of mitosis, but in the resumption
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of normal cell cycle progression. The results presented here are consistent
with the hypothesis that the cell cycle is regulated in dimensions of both time
(the timely synthesis and proteolysis of regulatory proteins) and space
(local ising these regulators to the correct site) and that methylxanthines like
pentoxifylline act at both levels to disrupt the G2 cell cycle delay. The
manipulation of cell cycle checkpoints remain an important topic, not only in
the application of methylxanthines like pentoxifylline, but also in general for
new strategies in anti-cancer therapy.
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Chapter 6
General Conclusions
The human melanoma cell lines 8e11 and MeWo, the human SCC cell lines
4197 and 4451, and the human lymphocytic leukemia cell line, Jurkat J5,
were used to investigate the role of the G2 cell cycle delay, DNA repair and
apoptosis in cellular radiosensitisation by the methylxanthine drug,
pentoxifylline. The Hela human cervical carcinoma cell line was used to
study the target molecules and mechanisms involved in the abrogation of the
G2 block by pentoxifylline.
The results of this study demonstrate that G2 block abrogation is not the main
mechanism involved in the radiosensitising effect of pentoxifylline, which is
selective for TP53 mutant cell lines. This observation disqualifies several
previous suggestions from the literature that the early enforcement of mitosis
by the drug plays a major role in the enhancement of radiotoxicity (O'Connor
et al, 1996; Husain et al, 1998; Li et al, 1998).
It is concluded that DNA repair inhibition and the modulation of radiation-
induced apoptosis also play roles in the mechanism of action of pentoxifylline
as a radiosensitiser, depending on cell type. In the TP53 mutant MeWo
melanoma cell line, DNA repair inhibition is larger by a factor of 1.7 compared
to that in the TP53 wild type 8e11 melanoma cell line. This strongly
correlates with the radiosensitisation effects measured in the melanoma cell
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pair. Although the two melanoma cell lines studied here are non-syngeneic,
these observations suggest an opportunity to attain a favourable therapeutic
index with pentoxifylline in this tumour type. This is particularly relevant as
mutations in TP53 is the most frequently noted gene alteration in the
pathogenesis of malignant melanoma, and currently receives a lot of attention
for its potential as prognostic indicator (Weiss et ai, 1995). The specific
mechanisms involved in DNA repair inhibition remains to be elucidated, but
may involve the ataxia telangiectasia mutant (ATM)-related DNA-PK protein
which is activated in response to DNA damage and plays an important role in
DNA repair (Sarkaria et al, 1999).
That the DNA repair inhibition effect is cell type specific is clearly
demonstrated by the fact that no correlation was seen between
radiosensitisation and DNA repair inhibition in the 4197 and 4451 sec cell
lines. It is noted that the two sec cell lines lack the correspondence
between radiosensitivity, normal DNA repair capability and TP53 status seen
in the melanoma cells, but still show preferential radiosensitisation of the
TP53 cell line with pentoxifylline.
Induction of apoptotic pathways plays no role in the radiosenstisation of the
two TP53 mutant cell lines MeWo and 4451. An increase in radiation-induced
apoptosis is however evident in the Jurkat J5 lymphocytic leukemia cell line,
which suggests that the effect of pentoxifylline on apoptosis is also cell type
specific. While an enhancement of radiation-induced apoptosis by
pentoxifylline may be expected in cells normally dying via apoptotic pathways
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following radiation damage, this effect has also been demonstrated for
caffeine in Hela cells which normally die by mitotic death (Bernhard et ai,
1996). If the induction of apoptosis by methylxanthines is not dependent on
TP53 status or cellular origin, the identification of cell types likely to show
increased apoptosis with pentoxifylline requires further investigation. The
possibility that DNA repair inhibition or apoptosis induction and G2 block
abrogation may act in concert to enhance radiotoxicity, cannot be excluded.
Taking into consideration the rather short plasma half lives of pentoxifylline
and its metabolites (Honess et ai, 1993), it is not surprising that the early
damage responses like repair and apoptosis playa role in radiosensitisation.
The formation of the G2 block is a relatively slow response which generally
occurs over approximately 24h after irradiation. The mechanism of action of
pentoxifylline as a G2 block abrogator is of critical importance in cancer
therapy, because tumour cells can be sensitised to a second therapeutic
insult by this approach (Wang et al, 1996; Binder et al, 2000).
By calculating cyclin B1/p34cdc2 ratios, it is demonstrated that pentoxifylline
stimulates cyclin B1 expression during G2 block abrogation. This novel
approach may also explain contradictions in literature. A rise in cyclin B1
expression, due to the rise in the G2 population during G2 block formation,
identified as increased cyclin B1 expression during G2 arrest (Smeets et ai,
1994) may be an error because it neglects the level of G2 cells which also
increases. My experiments on p34cdC2 suggest an ultrasensitive "switch"
which consists of two components (cyclin B1 and p34CdC2). The ratio of these
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two molecules is rapidly restored to control levels by pentoxifylline. The
nuclear export of MPF after G2 block abrogation is also demonstrated. It is
not known whether this modulation of cyclin 81 and p34cdC2 expression is a
direct or an indirect effect involving signal transduction pathways. The
possibility exists that pentoxifylline may influence kinases involved in the
phosphorylation steps responsible for MPF activity. This is supported by a
recent study on caffeine-mediated suppression of the ATM and ATR kinases
needed for inhibitory phosphorylation of p34cdC2 (Sarkaria et ai, 1999) and is
also in line with the known function of pentoxifylline as a phosphodiesterase
inhibitor.
The results presented here contribute greatly to a better understanding of the
mechanism of action of pentoxifylline, both as radiosensitiser and as G2 block
abrogator. The neccessity for an independent evaluation of these two effects
is a novel concept. These results furthermore highlight that the drug is cell
type specific, and the need to identify tumour types likely to benefit from a
pentoxifylline/radiotherapy combination and treatment modalities likely to
show improved therapy outcome. The selective radiosensitisation of TP53
mutant cell lines by pentoxifylline shows that the clinical application of the
drug at a non-toxic dose indeed could lead to increased TP53 mutant tumour
cell death, while TP53 wild type surrounding normal tissue could be spared.
Since TP53 mutations occur in 60% of all tumour types, this drug and its
metabolites emerge as radiosensitisers with the potential of a marked
improvement of therapy. One could speculate that the benefit may be even
greater in a clinical setup involving tumour hypoxia, because pentoxifylline
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has the known effect of improving tumour vasculature, which could lead to an
oxygen enhancement ratio (OER) of larger than one.
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